6 completed, 1 recruiting. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lansoprazole Placebo: new trials by email Literature Review of Lansoprazole Placebo trials Research Report on Lansoprazole Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer Ilaprazole, Lansoprazole, Ilaprazole Placebo - Peptic Ulcer | Phase 3 | Recruiting | Il-Yang Pharm. Co., Ltd. | 416 | 2024-07-23 | 2025-05-30 |
| The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis X842, X842 Placebo, Lansoprazole - Reflux Esophagitis | Phase 3 | Completed | Jiangsu Sinorda Biomedicine Co., Ltd | 380 | 2021-06-24 | 2025-07-23 |
| Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis X842, X842 Placebo, Lansoprazole - Reflux Esophagitis | Phase 2 | Completed | Jiangsu Sinorda Biomedicine Co., Ltd | 90 | 2020-01-21 | 2025-07-17 |
| Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection TAK-438, Lansoprazole, TAK-438 Placebo - Gastric Ulcer | Phase 3 | Completed | Takeda | 234 | 2017-04-17 | 2021-06-18 |
| Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection TAK-438, Lansoprazole, TAK-438 Placebo - Duodenal Ulcer | Phase 3 | Completed | Takeda | 533 | 2017-04-05 | 2020-06-12 |
| Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis Vonoprazan, Lansoprazole, Vonoprazan Placebo - Erosive Esophagitis | Phase 3 | Completed | Takeda | 703 | 2015-04-01 | 2020-02-21 |
| Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis Vonoprazan, Lansoprazole, Vonoprazan Placebo - Erosive Esophagitis | Phase 3 | Completed | Takeda | 481 | 2015-03-24 | 2019-06-03 |
Esophagitis, Peptic (2) · Digestive System Diseases (1) · Duodenal Ulcer (1) · Gastroesophageal Reflux (1) · Gastrointestinal Diseases (1) · Peptic Ulcer (1) · Stomach Ulcer (1)
Takeda (4) · Jiangsu Sinorda Biomedicine Co., Ltd (2) · Il-Yang Pharm. Co., Ltd. (1)
China (6) · South Korea (5) · Taiwan (4) · Malaysia (2) · Philippines (2)
Pingsheng Hu, Ph.D (2) · JungSoo Song, M.D. (1)